Man Group plc - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Man Group plc ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$36,938
+39.3%
94,956
+59.9%
0.00%
Q2 2023$26,520
-99.6%
59,396
-92.6%
0.00%
-100.0%
Q4 2020$7,062,000
+115.6%
797,994
+182.5%
0.03%
+138.5%
Q3 2020$3,276,000
-68.8%
282,448
-27.4%
0.01%
-75.5%
Q2 2020$10,486,000
+1484.0%
389,093
+130.2%
0.05%
+1666.7%
Q2 2018$662,000
-16.8%
169,0000.0%0.00%
-25.0%
Q1 2018$796,000169,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders